share_log

Maravai LifeSciences Q1 2024 Adj EPS $(0.02) Beats $(0.03) Estimate, Sales $64.179M Beat $60.548M Estimate

Benzinga ·  May 8 16:22

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $64.179 million which beat the analyst consensus estimate of $60.548 million by 6.00 percent. This is a 18.79 percent decrease over sales of $79.025 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment